Life Sciences
99 VCs and 58 funds investing in Life Sciences
VCs investing in Life Sciences
Nimi Katragadda
Partner
BoxGroup
Check: BoxGroup currently publishes a firm-wide maximum investment of $1M. Historical sources reported smaller firm checks and third-party profiles estimate $250K–$750K for Nimi, but no primary source confirms a current personal range.
Nimi is a generalist early-stage Partner with a long-running, publicly documented focus on healthcare and life sciences, fintech, marketplaces, and software. Her current activity extends that lens into AI-native healthcare, scientific agents, enterprise AI, and the financial infrastructure surrounding AI use. She applies BoxGroup's founder-first philosophy while testing whether the operating model, retention, sequencing, and economics can support the founder's category-scale ambition.
Meagan Malm
Partner and Director of Operations
Michigan Capital Network
Check: Michigan Capital Network does not publish a standard current check-size range on its official site.
Meagan Malm is listed in a Partner and Director of Operations capacity at Michigan Capital Network. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Jessica Owens
Co-Founder and General Partner
INITIATE Ventures
Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.
Jessica Owens invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.
Riley Shelton
Associate, Investments
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Riley Shelton invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Iana Dimkova
Co-Founder and General Partner
INITIATE Ventures
Check: $500K-$3M checks were disclosed at launch; no person-specific range is public.
Iana Dimkova invests or supports investments through INITIATE Ventures's published strategy: Build and back AI-native healthcare and life-sciences companies, combining investing with hands-on company initiation by experienced healthcare operators.
Melinda Gloriosa
Vice President, Investments
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Melinda Gloriosa invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Srini Koushik
Venture Partner, AI
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Srini Koushik invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Justin Probst
Vice President, Finance and Operations
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Justin Probst is listed in a Vice President, Finance and Operations capacity at R1 Capital. The firm does not publish a person-specific investment thesis for this role; the profile therefore preserves the role distinction and uses the firm's public mandate only as shared context.
Meghan Hoffman
Associate, Life Sciences Investments
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Meghan Hoffman invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Omar Yamout
Associate
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Omar Yamout invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Grant Berliner
Associate, Investments
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Grant Berliner invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Parker MacDonell
Venture Partner
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Parker MacDonell invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Wayne Embree
Venture Partner
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Wayne Embree invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Verlensia Bates
Accounting and Operations Coordinator
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Verlensia Bates is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Ken Hall
Vice President
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Ken Hall is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Howard Cox
Special Limited Partner
Greylock Partners
Check: No current personal or Greylock check range is attributable to Howard, and his emeritus Special Limited Partner status should not be treated as current check-writing authority. Contact Greylock's active investors for stage, allocation, ownership and process.
Howard's record reflects a long-horizon institution-builder and governance lens developed across Greylock, the NVCA, In-Q-Tel, Stryker, investment committees and public-interest institutions. It is useful for evaluating leadership, board quality, stewardship and the relationship between private innovation and enduring institutions, but it is historical/advisory—not a current personal sourcing thesis.
Shahram Seyedin-Noor
Founder + Managing Partner
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Shahram Seyedin-Noor invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Sonia Setayesh
Investment Partner
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Sonia Setayesh invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Manuel Lopez-Figueroa
Operating Partner
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Manuel Lopez-Figueroa invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Sarah Loveland
Senior Associate
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Sarah Loveland invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Angelica Parente
Operating Partner
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Angelica Parente invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
David Narrow
Venture Advisor
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
David Narrow is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Carli Kaleta
Associate Intern
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Carli Kaleta invests or supports investments through Civilization Ventures's published strategy: Back founders redefining human health and lifespan through biotechnology, diagnostics, therapeutics and AI-enabled life sciences.
Matt Wheeler
CFO
Civilization Ventures
Check: Civilization Ventures does not publish a standard check-size range on its official site.
Matt Wheeler is listed in a CFO capacity at Civilization Ventures. The official roster does not establish a personal investment mandate for this role; the firm's strategy is included only as organizational context.
Mark Gorenberg
Founder & Managing Director
Zetta Venture Partners
Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.
Mark Gorenberg invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.
Apoorva Pandhi
Managing Director
Zetta Venture Partners
Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.
Apoorva Pandhi invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.
Jocelyn Goldfein
Managing Director
Zetta Venture Partners
Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.
Jocelyn Goldfein invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.
Dylan Reid
Managing Director
Zetta Venture Partners
Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.
Dylan Reid invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.
Annelies Gamble
Partner
Zetta Venture Partners
Check: Zetta Venture Partners does not publish a standard current check-size range on its official site.
Annelies Gamble invests or supports investments through Zetta Venture Partners's published strategy: Be a first believer in AI-native founders building enterprise applications, infrastructure and technically ambitious companies where learning systems create the core advantage.
Mitchel Laskey
Managing Partner
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Mitchel Laskey is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Scott Addonizio
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Scott Addonizio is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Will Cadell
Venture Advisor
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Will Cadell is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Andy Dearing
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Andy Dearing is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Joel Crater
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Joel Crater is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Caleb Eidem
General Counsel
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Caleb Eidem is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Scott Herman
Venture Advisor
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Scott Herman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Elise Miller Hoffman
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Elise Miller Hoffman is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Cliff Holekamp
Co-Founder & General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Cliff Holekamp is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Kristina Hood
Principal
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Kristina Hood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Kyle Kerns
CFO and Operations Lead
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Kyle Kerns is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Catherine Matthes
Venture Advisor
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Catherine Matthes is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Brian Matthews
Co-Founder & General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Brian Matthews is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Paul Meier
Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Paul Meier is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Sean Morris
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Sean Morris is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Dennis Muilenburg
Venture Advisor
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Dennis Muilenburg is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Jacob Schpok
Partner and Head of Platform
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Jacob Schpok is listed in a Partner and Head of Platform capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Matt Phimphavong
Principal
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Matt Phimphavong is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Grant Pothast
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Grant Pothast is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Rick Ryan
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Rick Ryan is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Bobby Sandage
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Bobby Sandage is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Martha Schlicher
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Martha Schlicher is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Barry Sandweiss
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Barry Sandweiss is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Bill Schmidt
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Bill Schmidt is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
David Smoller
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
David Smoller is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Timothy Stern
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Timothy Stern is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
John True
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
John True is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Paul Weber
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Paul Weber is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Kyle Welborn
Co-Founder & General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Kyle Welborn is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Heather Wood
General Partner
Cultivation Capital
Check: $100K-$3.5M firm investment range published by Cultivation Capital; person-specific checks are not disclosed.
Heather Wood is part of Cultivation Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Invest in promising seed-through-Series-B companies across software, life sciences, health, agriculture, food, and geospatial technology, with a strong Midwest network.
Ben Patz
Managing Partner
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Ben Patz is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Kathy Chiu
Managing Partner
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Kathy Chiu is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Kim Garland
Venture Partner
R1 Capital
Check: R1 Capital does not publish a standard person-specific check-size range on its current website.
Kim Garland invests or supports investments through R1 Capital's published strategy: Back technically advantaged, capital-efficient companies in large scalable markets and support founders from proof of concept through growth using a national network and Rev1 partnership.
Jody Vanderwel
Founding Partner
Michigan Capital Network
Check: Michigan Capital Network does not publish a standard current check-size range on its official site.
Jody Vanderwel invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.
Jackson Streeter, MD
Venture Partner
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Jackson Streeter, MD is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Kristopher Lancaster
Associate
DeepWork Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Kristopher Lancaster is part of DeepWork Capital's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Back seed and Series A technology and life-science companies in Florida and other undercapitalized U.S. markets where hands-on support can compound regional advantages.
Stacey Barnes
Senior Business Operations Manager
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Stacey Barnes is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Henry Haverty
Accounting Intern
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Henry Haverty is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Logan Hille, Ph.D.
Life Sciences Analyst
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Logan Hille, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Kerry Hull, CPA, MBA
Chief Financial Officer & Chief Operating Officer
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Kerry Hull, CPA, MBA is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Sean Kwiat
Vice President, Investments
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Sean Kwiat is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Liam McAllister
Investment Analyst
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Liam McAllister is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Bryan McCleary
Executive in Residence
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Bryan McCleary is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Kenneth Morand, Ph.D.
Life Sciences Partner
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Kenneth Morand, Ph.D. is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Emma Off
CEO, President, & Partner
CincyTech
Check: The firm does not publish a person-specific check-size range on its current official website.
Emma Off is part of CincyTech's current team. No narrower person-specific investment mandate is published, so this profile uses the firm's official strategy: Partner early with founders, researchers, and inventors building technology and life-science companies around difficult, high-impact problems.
Maureen Stancik Boyce, PhD
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Maureen Stancik Boyce, PhD is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Amy Salzhauer
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Amy Salzhauer is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Carolyne LaSala
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Carolyne LaSala is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
David Mendez
Managing Partner
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
David Mendez is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Sophie Hagerty
Principal
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Sophie Hagerty is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Aditi Rajagopal
Principal
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Aditi Rajagopal is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Ziad Sarby
Associate
Good Growth Capital
Check: The firm does not publish a person-specific check-size range on its current official website.
Ziad Sarby is part of Good Growth Capital's current team. No narrower person-specific mandate is published, so this profile uses the firm's official strategy: Identify hidden early potential in life sciences, data science, green technology, advanced materials, and other technically defensible innovations.
Marc Averitt
Co-Founder, Managing Director
Okapi Venture Capital
Check: Okapi Venture Capital does not publish a standard check-size range on its official site.
Marc Averitt invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.
Jeff Bocan
Managing Director
Okapi Venture Capital
Check: Okapi Venture Capital does not publish a standard check-size range on its official site.
Jeff Bocan invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.
John Waller
Managing Director, Venture Partner
Okapi Venture Capital
Check: Okapi Venture Capital does not publish a standard check-size range on its official site.
John Waller invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.
Sharon Stevenson
Co-Founder, Managing Director, Venture Partner
Okapi Venture Capital
Check: Okapi Venture Capital does not publish a standard check-size range on its official site.
Sharon Stevenson invests or supports investments through Okapi Venture Capital's published strategy: Back seed and early-stage information-technology and life-science companies, with deep roots in Southern California.
Hayes Barnes
Director of Marketing
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Hayes Barnes is listed in a Director of Marketing capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Marli Carmack
Office Manager
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Marli Carmack is listed in a Office Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Andie Hines-Lagemann
Director of Engagement and EQ Practitioner
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Andie Hines-Lagemann invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.
Chris Huxhold
Chief Financial Officer
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Chris Huxhold is listed in a Chief Financial Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Brighid King
Platform Operations Manager
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Brighid King is listed in a Platform Operations Manager capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Nicholas Kuhn
Vice President of Hardtech
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Nicholas Kuhn invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.
Phil Lodato
General Counsel and Chief Compliance Officer
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Phil Lodato is listed in a General Counsel and Chief Compliance Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Makenzie Norris
Vice President of Life Sciences
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Makenzie Norris invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.
Dale Grogan
Managing Partner
Michigan Capital Network
Check: Michigan Capital Network does not publish a standard current check-size range on its official site.
Dale Grogan invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.
Erica Schweyer
Chief of Staff
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Erica Schweyer is listed in a Chief of Staff capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Muhammad Yasin
Chief Marketing Officer
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Muhammad Yasin is listed in a Chief Marketing Officer capacity at Elevate Ventures. The firm does not publish a person-specific investment thesis for this role; the profile preserves that role distinction and uses the firm's mandate only as shared context.
Landon Young
Vice President of Pre-Seed
Elevate Ventures
Check: $20K-$2M in a round and up to $8M in a company, depending on stage and growth, as published by Elevate Ventures.
Landon Young invests or supports investments through Elevate Ventures's published strategy: Invest in high-potential innovation-driven companies while pairing strategic capital with programs, mentorship, networks and portfolio support.
Paul D'Amato
Chief Executive Officer and Founding Partner
Michigan Capital Network
Check: Michigan Capital Network does not publish a standard current check-size range on its official site.
Paul D'Amato invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.
Lynn Bishop
Operating Partner
Michigan Capital Network
Check: Michigan Capital Network does not publish a standard current check-size range on its official site.
Lynn Bishop invests or supports investments through Michigan Capital Network's published strategy: Use financial, technical and relationship capital to back capital-efficient early-stage companies, with a strong focus on Michigan and the Midwest.
Funds focused on Life Sciences
Forbion
Naarden, Netherlands
Cambridge Innovation Capital
Cambridge, United Kingdom
Inveready
Barcelona, Spain
Bayern Kapital
Landshut, Bavaria, Germany
Anzu Partners
Boston / San Diego / Tampa / Washington, DC / Atlanta
AUM: Approximately $1B
Portugal Ventures
Porto and Lisbon, Portugal
Elaia
Paris, France
Seventure Partners
Paris, France
Investinor
Trondheim, Norway
PSV
Kongens Lyngby, Denmark
Cultivation Capital
St. Louis, Missouri
Innovestor
Helsinki, Finland
Industrifonden
Stockholm, Sweden
Parkwalk Advisors
London, United Kingdom
M Ventures
Amsterdam, Netherlands
Wellington Partners
Munich, Germany
DeepTech & Climate Fonds
Berlin, Bonn and Munich, Germany
Elevate Ventures
Indianapolis, Indiana
Innovation Industries
Amsterdam, Netherlands
NRW.Venture
Düsseldorf, Germany
BioGeneration Ventures
Naarden, Netherlands
Hadean Ventures
Oslo, Norway and Stockholm, Sweden
Mercia Ventures
United Kingdom
Michigan Capital Network
Grand Rapids, Michigan
Vi Partners
Switzerland
Newton Biocapital
Brussels, Belgium and Tokyo, Japan
Safar Partners
Cambridge, Massachusetts
Brandenburg Kapital
Potsdam, Germany
Claris Ventures
Turin, Italy
Panakès Partners
Milan, Italy
Clarevia
Madison, Wisconsin
Sandwater
Oslo, Norway
redalpine
Zurich, Switzerland
Sarsia
Bergen, Norway
Navigare Ventures
Stockholm, Sweden
R1 Capital
Columbus, Ohio
Heal Capital
Berlin, Germany
Michigan Rise
East Lansing, Michigan
XISTA Science Ventures
Vienna, Austria
CincyTech
Cincinnati, Ohio
Metavallon VC
Athens, Greece
Civilization Ventures
San Francisco, California
Thuja Capital
Utrecht, Netherlands
i&i Bio
Prague, Czechia
MassVentures
Waltham, Massachusetts / Worcester, Massachusetts
Practica Capital
Vilnius, Lithuania
Nordic Science Investments
Helsinki, Finland
DeepWork Capital
Orlando, Florida
Good Growth Capital
Charleston, South Carolina
V-Bio Ventures
Ghent, Belgium
Voima Ventures
Helsinki, Finland
Kickfund
Basel, Switzerland
Vesalius Biocapital
Luxembourg
OCCIDENT
Munich, Germany and Zug, Switzerland
Okapi Venture Capital
Newport Beach, California
Zetta Venture Partners
San Francisco, California
Possible Ventures
Munich, Germany
INITIATE Ventures
United States